Document is current
Any future updates will be listed below
-
Authors
Noor, Asif
McGowan, Emily R.
Van Zuylekom, Jessica K.
Cullinane, Carleen
Roselt, Peter D.
Hicks, Rodney J.
Wheatcroft, Michael P.
Donnelly, Paul S. https://orcid.org/0000-0001-5373-0080
-
Funding
Funding for this research was provided by:
Australian Research Council (Australian Research Council)
National Health and Medical Research Council (National Health and Medical Research Council)
Innovative Manufacturing CRC (Innovative Manufacturing CRC)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 12 November 2024
First Online: 26 November 2024
Declarations
:
: All animal experiments were performed with the approval of the Peter MacCallum Cancer Centre Animal Experimentation Ethics Committee and in accordance with the Australian code for the care and use of animals for scientific purposes (8th Edition, 2013).
: Not applicable.
: Asif Noor, Peter Roselt and Paul Donnelly are listed as inventors on intellectual property relating to aspects of this research. Paul Donnelly is a shareholder of Clarity Pharmaceuticals and Telix Pharmaceuticals. Michael Wheatcroft is an employee of Telix Pharmaceuticals. Rodney Hicks is a shareholder of Telix Pharmaceuticals and serves on the Scientific Advisory Board.
